FDA
-
-
-
-
-
-
-
Deutsche Bank on Bristol-Myers Squibb Co. (BMY): FDA Approval of KarMMA-3 Meets Commercial Reality Check
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Provides Update on the First Phase 3 YELLOWSTONE Trial of Oral Zeposia
-
-
-
-
-
-
-
Bristol Myers Squibb and Ted Danson Empower Those with Plaque Psoriasis to Take Action in “SO, Have You Found It?” Campaign
-
-
-
-
-
-
-
US FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Announces FDA Acceptance for Priority of Application for Augtyro
-
-
-
-
-
-
-
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Reports Eight-Year Data for Opdivo Plus Yervoy Continued to Demonstrate Longest Survival Benefit vs. Sunitinib
-
251,959 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All